Engaged Capital Reaches Agreement with Evolent Health for Board Representation

Olshan client Engaged Capital reached an agreement with Evolent Health pursuant to which Brendan Springstubb, a former partner at Engaged Capital, was appointed to Evolent Health’s board and one incumbent director resigned from the board. As part of the agreement, Mr. Springstubb was also appointed to the Strategy Committee of the board. Evolent Health also announced plans to name a new Chair of the board and appoint an additional independent director at the upcoming annual meeting. Vice Chair of Olshan’s Shareholder Activism Practice Group Ryan Nebel, Ian Engoron and Joseph Ferrone represented Engaged Capital in connection with its investment in Evolent Health.